Elenco degli articoli con argomento «Ruxolitinib»
Dermatologia16 lug 2026
Survey: uso di tacrolimus e pimecrolimus nella vitiligine
Survey promossa dal Dott. Andrea Paro Vidolin e MELATASK - SIDeMaST Malattie della Pigmentazione Task Force
20 nov 2025
Topical ruxolitinib ± oral baricitinib in the treatment of active non-segmental vitiligo
A retrospective analysis
23 giu 2025
Off-Label Use of Topical Ruxolitinib in Dermatology
JAK inhibitors are used to treat various inflammatory skin disease
15 gen 2025
Reply to incidence of nonmelanoma skin cancer in patients with vitiligo
Reply to ‘incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream’
03 ott 2022
FDA approves Ruxolitinib
The Food and Drug Administration (FDA) has authorized Ruxolitinib (Opzelura)